Familial Hypercholesterolemia
Clinical Trials Update
Dear  ,

Our mission is to empower those with familial hypercholesterolemia (FH) with the knowledge and tools to get the best care possible for longer and healthier lives.
 
You are receiving this email because you signed up for Clinical Trial Updates from the FH Foundation.
 
Even with the treatments available for FH, more research is needed.
 
These clinical trials are currently enrolling individuals with FH, including trials that are specific to homozygous FH. Click on the ClinicalTrials.gov Identifier links for more details.
Name
Adult or Pediatric
Population
ClinicalTrials.gov
 Identifier
CASCADE FH ™ Registry
Adults and Pediatric Heterozygous FH and Homozygous FH
Evolocumab
 (AMG 145)
Pediatric
Heterozygous FH and Homozygous FH
Alirocumab
Adults and Pediatric
Heterozygous FH
Bempedoic Acid 
(ETC-1002)
Adults
Heterozygous FH and Statin Intolerant
MGL-3196
Adults
Heterozygous FH
IONIS ANGPTL3-LRx
Adults
Heterozygous FH and Homozygous FH
ALN-PCSSC
Adults
Homozygous FH
Gemcabene
Adults
Homozygous FH
Genetic AAV directed hLDLR Gene Therapy
Adults
Homozygous FH
Evolocumab Pregnancy 
Exposure Registry
Adults
Hypercholesterolemia Pregnancy
Some of these trials are conducted nationally, and others are only recruiting in certain geographic areas. If you have a question about enrolling in a clinical trial in your area, or would like to learn more about trials enrolling individuals with all forms of hypercholesterolemia (not just FH), please contact The FH Foundation® at  (626) 583-4674 or Elaiza Torralba at [email protected].  We would be very happy to help you with any questions you have.

To learn more about clinical trials click here.
Stay Informed

 
Want to be in the know?  Join our mailing list and receive updates on all  news relating to  familial hypercholsterolemia and the FH Foundation.